SEITO Biologics AG
PrivateLast Round
Early Funding
Jun 3, 2025
Total Funding Raised
$3.44M
Company Overview
SEITO Biologics AG is a biotechnology company that develops targeted cytokine therapies, specifically selective Treg cell engagers (TREX), to restore immune balance in patients with autoimmune and chronic-inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SEITO Biologics AG Comparables
Compare SEITO Biologics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dualyx | 81% | |
| Quell Therapeutics | 78% | |
| Egle Therapeutics | 77% | |
SEITO Biologics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 3, 2025 |
SEITO Biologics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lichtsteiner Foundation | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 65% MoM, reaching 1.3K.
SEITO Biologics AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SEITO Biologics AG's valuation, stock price, and market status.